Literature DB >> 2156641

Interleukin-6 and ACTH act synergistically to stimulate the release of corticosterone from adrenal gland cells.

M A Salas1, S W Evans, M J Levell, J T Whicher.   

Abstract

We investigated whether interleukin-6 (IL-6) could cause the release of corticosterone by a direct interaction with the adrenal gland. Primary cultures of rat adrenal glands were obtained by dispersion with collagenase and incubated for 24 h with different doses of IL-6. Levels of corticosterone were measured by competitive protein binding assay. A significant (P less than 0.025) dose-dependent increase in corticosterone levels was seen at all doses used. Time course experiments demonstrated that IL-6 stimulated corticosterone release over a period of 24 h but not after 12 or 3 h. The stimulation of adrenal cells with different doses of ACTH1-24 and 40 U/ml of IL-6 showed a synergistic effect when IL-6 was combined with low concentrations of ACTH1-24 (2 and 20 pmol/l). This effect was not evident at higher doses. Our results suggest that IL-6 may act at different levels of the hypothalmic pituitary adrenal axis. Moreover the finding of a synergistic effect with ACTH1-24 indicates that IL-6 could play a role in the long term response to stress.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2156641      PMCID: PMC1534960          DOI: 10.1111/j.1365-2249.1990.tb08114.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  22 in total

1.  Monocytes stimulate cortisol production by cultured human adrenocortical cells.

Authors:  R W Whitcomb; W M Linehan; L M Wahl; R A Knazek
Journal:  J Clin Endocrinol Metab       Date:  1988-01       Impact factor: 5.958

2.  Release of multiple hormones by a direct action of interleukin-1 on pituitary cells.

Authors:  E W Bernton; J E Beach; J W Holaday; R C Smallridge; H G Fein
Journal:  Science       Date:  1987-10-23       Impact factor: 47.728

3.  Interleukin-1 directly stimulates the release of corticotrophin releasing factor from rat hypothalamus.

Authors:  S Tsagarakis; G Gillies; L H Rees; M Besser; A Grossman
Journal:  Neuroendocrinology       Date:  1989-01       Impact factor: 4.914

4.  Catecholamine stimulation of cortisol secretion by 3-day primary cultures of purified zona fasciculata/reticularis cells isolated from bovine adrenal cortex.

Authors:  S W Walker; E R Lightly; S W Milner; B C Williams
Journal:  Mol Cell Endocrinol       Date:  1988-05       Impact factor: 4.102

5.  Interleukin-6 stimulates the secretion of adrenocorticotropic hormone in conscious, freely-moving rats.

Authors:  Y Naitoh; J Fukata; T Tominaga; Y Nakai; S Tamai; K Mori; H Imura
Journal:  Biochem Biophys Res Commun       Date:  1988-09-30       Impact factor: 3.575

6.  Interleukin 6 is involved in interleukin 1-induced activities.

Authors:  M Helle; J P Brakenhoff; E R De Groot; L A Aarden
Journal:  Eur J Immunol       Date:  1988-06       Impact factor: 5.532

7.  Interleukin 6, the third mediator of acute-phase reaction, modulates hepatic protein synthesis in human and mouse. Comparison with interleukin 1 beta and tumor necrosis factor-alpha.

Authors:  G Ramadori; J Van Damme; H Rieder; K H Meyer zum Büschenfelde
Journal:  Eur J Immunol       Date:  1988-08       Impact factor: 5.532

8.  Transcriptional regulation of the interferon-beta 2/B cell differentiation factor BSF-2/hepatocyte-stimulating factor gene in human fibroblasts by other cytokines.

Authors:  Z Walther; L T May; P B Sehgal
Journal:  J Immunol       Date:  1988-02-01       Impact factor: 5.422

9.  Recombinant human interleukin-6 (IL-6/BSF-2/HSF) regulates the synthesis of acute phase proteins in human hepatocytes.

Authors:  J V Castell; M J Gómez-Lechón; M David; T Hirano; T Kishimoto; P C Heinrich
Journal:  FEBS Lett       Date:  1988-05-23       Impact factor: 4.124

10.  Glucocorticoids selectively inhibit the transcription of the interleukin 1 beta gene and decrease the stability of interleukin 1 beta mRNA.

Authors:  S W Lee; A P Tsou; H Chan; J Thomas; K Petrie; E M Eugui; A C Allison
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

View more
  25 in total

Review 1.  Hormonal control of T-cell development in health and disease.

Authors:  Wilson Savino; Daniella Arêas Mendes-da-Cruz; Ailin Lepletier; Mireille Dardenne
Journal:  Nat Rev Endocrinol       Date:  2015-10-06       Impact factor: 43.330

2.  Early menopause, low body mass index, and smoking are independent risk factors for developing giant cell arteritis.

Authors:  K Larsson; D Mellström; E Nordborg; C Nordborg; A Odén; E Nordborg
Journal:  Ann Rheum Dis       Date:  2005-08-26       Impact factor: 19.103

3.  Organization and Integration of the Endocrine System.

Authors:  George P Chrousos
Journal:  Sleep Med Clin       Date:  2007-06

4.  Expression of cyclooxygenase enzymes in rat hypothalamo-pituitary-adrenal axis: effects of endotoxin and glucocorticoids.

Authors:  P O Cover; D Slater; J C Buckingham
Journal:  Endocrine       Date:  2001-11       Impact factor: 3.633

Review 5.  IL-6-like cytokines and cancer cachexia: consequences of chronic inflammation.

Authors:  B E Barton
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

6.  Suppression of chronic experimental autoimmune neuritis by nasally administered recombinant rat interleukin-6.

Authors:  G Deretzi; S Pelidou; L Zou; C Quiding; E Mix; M Levi; B Wahren; J Zhu
Journal:  Immunology       Date:  1999-05       Impact factor: 7.397

Review 7.  Immune modulation of the hypothalamic-pituitary-adrenal (HPA) axis during viral infection.

Authors:  Marni N Silverman; Brad D Pearce; Christine A Biron; Andrew H Miller
Journal:  Viral Immunol       Date:  2005       Impact factor: 2.257

8.  Effects of total intravenous anesthesia with propofol on immuno-endocrine changes during surgical stress.

Authors:  Tetsuhiro Sakai; David O'Flaherty; Adolf H Giesecke; Akira Kudo; Kazuyoshi Hirota; Akitomo Matsuki
Journal:  J Anesth       Date:  1995-09       Impact factor: 2.078

Review 9.  [Immunological aspects of depressive disorders].

Authors:  N Müller; M J Schwarz
Journal:  Nervenarzt       Date:  2007-11       Impact factor: 1.214

10.  Corticotropin-releasing hormone deficiency is associated with reduced local inflammation in a mouse model of experimental colitis.

Authors:  Jérôme Gay; Efi Kokkotou; Michael O'Brien; Charalabos Pothoulakis; Katia P Karalis
Journal:  Endocrinology       Date:  2008-04-10       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.